What Biotech does

Biotech Healthcare is a privately held global medical device company founded in 1999 by Mehul Asnani, organized as a group of legally independent companies under Biotech Healthcare Holding GmbH in Switzerland. The company designs, develops, manufactures, and sells specialty medical devices across three healthcare verticals: ophthalmology (its primary segment), orthopedics, and aesthetics. The ophthalmology portfolio is the most comprehensive and includes intraocular lenses (monofocal, toric, EDOF, and trifocal under the Optiflex brand), phakic lenses (Eyecryl) for refractive correction, ophthalmic viscosurgical devices (OVDs), surgical dyes, vitreoretinal temponades, intrastromal corneal ring segments (ISCR), and riboflavin for corneal cross-linking. The orthopedics vertical centers on OPTIVISC hyaluronic acid viscosupplement solutions for joint pain relief, and the aesthetics vertical offers hyaluronic acid dermal fillers.

The company's operating model is vertically integrated, with R&D and manufacturing facilities in Roscommon, Ireland (Biotech Europe Meditech Inc. Ltd.) and Ahmedabad, India (Biotech Vision Care Pvt. Ltd.), sales and marketing headquartered in Luzern, Switzerland, and distribution reaching more than 110 countries. Products are sold through B2B channels — direct to ophthalmologists, orthopedic surgeons, and aesthetic practitioners — typically via quote-based arrangements rather than disclosed pricing. The company invests in brand development through branded sub-portfolios (Optiflex, Eyecryl, Optivisc, Biotech Connect, ISCR), surgeon education via events such as the Global Phakic Users Meeting and major congresses like ESCRS, and digital infrastructure including a multilingual website in nine languages and the Biotech Connect mobile application for healthcare professionals. No institutional investors, venture capital backers, or parent company control signals were disclosed, suggesting founder or family ownership.

Name

Biotech

Legal name

Biotech Healthcare Holding GmbH

Website

https://biotechhealthcare.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Biotech Healthcare is a privately held Swiss-headquartered global medical device company founded in 1999 that designs, manufactures, and distributes intraocular lenses, phakic lenses, viscosupplements, and dermal fillers to ophthalmologists, orthopedic surgeons, and aesthetic practitioners across 110+ countries.

Ownership category

akta.pro rank

Product category

Medical Devices (Ophthalmology, Orthopedics, Aesthetics)

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

akta.pro secondary industry

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)

Keywords

• Ophthalmic medical devices
• Intraocular lenses
• Viscosupplement solutions
• Dermal fillers
• Refractive surgical products

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Products: Biotech Healthcare generates revenue through the sale of medical devices including intraocular lenses, phakic lenses, OVDs, viscosupplements, and dermal fillers to healthcare providers and surgical centers globally.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Biotech Healthcare manufactures and sells medical devices across three healthcare verticals: ophthalmology (intraocular lenses including monofocal, toric, EDOF, trifocal, and phakic lenses, plus OVDs, surgical dyes, temponades, riboflavin, and ISCR), orthopedics (OPTIVISC hyaluronic acid viscosupplement solutions for osteoarthritis), and aesthetics (hyaluronic acid dermal fillers). Products are sold B2B to ophthalmologists, surgeons, hospitals, and aesthetic practitioners in 110+ countries, with R&D and manufacturing in Ireland and India.

Product overview

Biotech Healthcare operates as a global medical technology company with three distinct healthcare verticals: Ophthalmology, Orthopedics, and Aesthetics. The Ophthalmology division encompasses a comprehensive portfolio of intraocular lenses (IOLs) including premium EDOF and trifocal products like Optiflex XTENSE Comfort Plus and Optiflex Trio Plus, phakic lenses (Eyecryl Phakic) for refractive correction, surgical aids (OVDs, dyes, temponades), and corneal procedures (ISCR, riboflavin). The Orthopedics segment centers on viscosupplementation with OPTIVISC hyaluronic acid products for joint pain relief. The Aesthetics vertical offers hyaluronic acid-based dermal fillers. The company distributes across 110+ countries with R&D and manufacturing facilities in Ireland and India, and sales headquarters in Switzerland.

Differentiator

Problem solved

Functional benefit

Brands

• Eyecryl: Phakic lens brand for vision correction
• Optiflex
• Optivisc
• Biotech Connect
• ISCR

Products and services

• Optiflex XTENSE Comfort Plus Premium extended-depth-of-focus (EDOF) intraocular lens for cataract surgery that provides continuous vision correction across distance and intermediate ranges with enhanced depth of focus.
• Optiflex Trio Plus Advanced intraocular lens combining trifocal and EDOF technologies to provide clear vision at near, intermediate, and distance ranges for cataract surgery patients.
• Eyecryl Phakic Implantable phakic intraocular lens for correction of moderate to severe myopia without removing the natural crystalline lens, designed for patients not suitable for laser refractive procedures.
• Intraocular Lenses (IOLs) Portfolio Full portfolio of intraocular lenses including monofocal, toric, EDOF, and multifocal/trifocal options for cataract surgery and refractive correction.
• OPTIVISC Viscosupplement Solutions Exogenous hyaluronic acid viscosupplement solutions for orthopedics that restore synovial fluid balance in osteoarthritis conditions, enhancing joint mobility and alleviating pain.
• Ophthalmic Viscosurgical Devices (OVDs) Viscoelastic substances used during ophthalmic surgery to maintain space, protect tissues, and facilitate manipulation during cataract and other eye procedures.
• Surgical Dyes Specialized staining solutions for ophthalmic surgery including trypan blue and brilliant blue G dyes for enhanced visualization during cataract procedures.
• Tamponades Vitreoretinal surgical products including silicone oil and perfluorocarbon liquids used as temporary internal tamponade agents during retinal detachment repair.
• Hyaluronic Acid Dermal Fillers Premium aesthetic injectable fillers based on hyaluronic acid for natural, long-lasting facial enhancements and wrinkle reduction.
• ISCR (Intrastromal Corneal Ring Segments) Corneal ring implants for treatment of keratoconus and corneal ectasia, providing structural support and vision correction.
• Riboflavin Ophthalmic Solutions Ophthalmic riboflavin solutions used in corneal cross-linking procedures for treatment of progressive keratoconus.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Oxford Nanopore TechnologiescoreTechnology or Integration · 9 October 2025Extended partnership through 2032 to develop genetic testing products using Oxford Nanopore's sequencing platforms. Collaboration builds on previous success with genetic screening kits and aims to accelerate diagnostic innovation and streamline workflows for genetic testing solutions globally.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Alcon: Global leader in ophthalmic surgical devices including IOLs (PanOptix, Vivity), phakic IOLs, and OVDs. Directly competes with Biotech Healthcare across the entire ophthalmology portfolio and acquired STAAR Surgical to extend phakic lens leadership.
• Johnson & Johnson Vision: Major ophthalmic medical device company offering TECNIS IOL family (monofocal, multifocal, EDOF) and surgical products. Directly competes with Biotech Healthcare in cataract surgery IOLs and refractive solutions.
• Bausch + Lomb: Diversified eye health company offering IOLs (enVista, LuxSmart), surgical instruments, and ophthalmic pharmaceuticals. Competes with Biotech Healthcare in IOLs and cataract surgical products.
• Carl Zeiss Meditec: Premium ophthalmic surgical microscope and IOL manufacturer (AT ELANA, CT LUCIA). Competes in the premium IOL segment and offers comprehensive cataract surgery solutions overlapping with Biotech Healthcare's portfolio.

Direct peers

• HOYA Surgical Optics: Division of HOYA Corporation manufacturing IOLs (Vivinex, iSert) for cataract surgery. Directly comparable in IOL portfolio breadth and global distribution, targeting similar ophthalmic surgeon customers.
• STAAR Surgical (now Alcon): Specialist in Implantable Collamer Lens (ICL) phakic IOLs for refractive correction. Closest direct competitor to Biotech Healthcare's Eyecryl phakic lens portfolio in the surgical refractive correction segment.
• Nidek: Japanese manufacturer of ophthalmic surgical equipment, IOLs, and diagnostic devices. Comparable in offering surgical ophthalmic devices across cataract and refractive categories with global distribution.
• Lenstec: Specialized IOL manufacturer focused on premium lens technologies including multifocal, toric, and EDOF IOLs. Directly comparable in scale and premium IOL portfolio positioning versus incumbent players.
• Santen Pharmaceutical: Specialty ophthalmology company with portfolio spanning cataract surgery, glaucoma, and dry eye. Comparable in ophthalmic vertical focus and global commercialization capabilities.

Emerging players

• VSY Biotechnology: Emerging ophthalmic medical device company with IOL portfolio and growing global presence. Similar in being a non-incumbent challenger with multi-product ophthalmology portfolio targeting premium IOL segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotech